No results, please enter a search term above
The Health Department has developed a webpage to help you track the number of monkeypox cases and vaccine availability in Philadelphia. This webpage will be updated every Monday.
|Date of Alert|
|No Health Alerts Found|
|Jynneos Eligibility Update||Update||Sep 1, 2022|
|Tecovirimat Treatment for Monkeypox||Update||Aug 22, 2022|
|Monkeypox Vaccination Update: Intradermal Injection Recommended||Advisory||Aug 18, 2022|
|Monkeypox Vaccination Strategy and Prioritization of First Doses||Advisory||Aug 4, 2022|
|Pain Management Recommendations for Monkeypox||Update||Aug 2, 2022|
Clinical presentation in the current outbreak has been atypical and often there is no prodrome. All patients have been found to have a skin rash upon physical examination, however the rash is often not scattered and is instead limited to one body site. Lymphadenopathy has not been universal during the current outbreak.
Key epidemiologic risk factors have included (1) contact with a person or people with a similar appearing rash or a diagnosis of monkeypox and (2) close or intimate contact with people in a social network experiencing monkeypox activity (e.g., men who have sex with men and transgender persons who have sex with men who meet partners through an online website, digital app, or social event).
The Health Department has begun vaccinating Philadelphians who are at high-risk. Currently, clinics are being offered on a rolling, invitation-only basis. Individuals who believe that they are at a high risk of being exposed to monkeypox can call the Call Center at 215-685-5488 to see if they are eligible to be vaccinated.
To be eligible, people must meet all of the following conditions:
Additionally, the following people are eligible:
The eligibility criteria has been established based on who may be at the highest-risk of exposure to monkeypox. As more vaccine is delivered, more people will be invited to these vaccine clinics.
While the vaccine is normally a 2-dose series, the Department of Public Health is currently only administering one dose to patients due to the limited supply of the vaccine. One dose still provides some protection against monkeypox and provides the opportunity to provide vaccine to more individuals who may be at high-risk of contracting monkeypox.
The following should be considered for management of suspected cases:
Testing is available through commercial laboratories (including LabCorp, Quest, and Mayo Clinic) as well as through the Pennsylvania Department of Health's Bureau of Laboratories (PADOH BOL). For additional details about the testing procedures for each lab, please refer to this document: Monkeypox Virus Testing Procedures For Labs
There are no patient or community resources for Monkeypox.
There are no posters for Monkeypox.